Down-regulation of lncRNA-NEAT1 alleviated the non-alcoholic fatty liver disease via mTOR/S6K1 signaling pathway.

about

Long noncoding RNA Hoxb3os is dysregulated in autosomal dominant polycystic kidney disease and regulates mTOR signaling.

P2860

Q54113169-001E2B54-3E78-46BE-9D94-5F0E48C42B19

P2860

Down-regulation of lncRNA-NEAT1 alleviated the non-alcoholic fatty liver disease via mTOR/S6K1 signaling pathway.

Item

http://www.wikidata.org/entity/Q47995053

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Down-regulation of lncRNA-NEAT ...... a mTOR/S6K1 signaling pathway.

@en

Down-regulation of lncRNA-NEAT ...... a mTOR/S6K1 signaling pathway.

@nl

type

Item

label

Down-regulation of lncRNA-NEAT ...... a mTOR/S6K1 signaling pathway.

@en

Down-regulation of lncRNA-NEAT ...... a mTOR/S6K1 signaling pathway.

@nl

prefLabel

Down-regulation of lncRNA-NEAT ...... a mTOR/S6K1 signaling pathway.

@en

Down-regulation of lncRNA-NEAT ...... a mTOR/S6K1 signaling pathway.

@nl

P1476

Down-regulation of lncRNA-NEAT ...... ia mTOR/S6K1 signaling pathway

@en

P2093

Xiang Wang

http://www.w3.org/2001/XMLSchema#string

P2860

SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

The Long Noncoding RNA NEAT1 Exerts Antihantaviral Effects by Acting as Positive Feedback for RIG-I Signaling.

MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease.

Long Non-Coding RNA NEAT1 Associates with SRp40 to Temporally Regulate PPARγ2 Splicing during Adipogenesis in 3T3-L1 Cells.

Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles

Long noncoding RNAs: Re-writing dogmas of RNA processing and stability.

Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD).

The role of mTOR in the adaptation and failure of beta-cells in type 2 diabetes.

Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes.

P304

1567-1574

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCB.26317

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P50

Xiang Wang

P577

2017-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28771824

http://www.w3.org/2001/XMLSchema#string

Down-regulation of lncRNA-NEAT1 alleviated the non-alcoholic fatty liver disease via mTOR/S6K1 signaling pathway.

about

P2860

P2860

Down-regulation of lncRNA-NEAT1 alleviated the non-alcoholic fatty liver disease via mTOR/S6K1 signaling pathway.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698